DI NARDO, FIAMMETTA
 Distribuzione geografica
Continente #
EU - Europa 549
AS - Asia 174
NA - Nord America 70
SA - Sud America 34
AF - Africa 6
Totale 833
Nazione #
RU - Federazione Russa 472
US - Stati Uniti d'America 61
SG - Singapore 60
IT - Italia 51
CN - Cina 50
VN - Vietnam 38
BR - Brasile 23
DE - Germania 7
HK - Hong Kong 7
AR - Argentina 6
MX - Messico 5
ID - Indonesia 4
JP - Giappone 4
KR - Corea 4
NL - Olanda 4
AT - Austria 3
CA - Canada 3
CO - Colombia 3
EG - Egitto 3
FR - Francia 3
GB - Regno Unito 3
EC - Ecuador 2
FI - Finlandia 2
PL - Polonia 2
ZA - Sudafrica 2
BD - Bangladesh 1
CR - Costa Rica 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
KE - Kenya 1
MY - Malesia 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 833
Città #
Moscow 179
Singapore 35
Dallas 16
San Jose 16
Ho Chi Minh City 13
Naples 11
Ashburn 9
Hanoi 9
Hefei 9
Beijing 7
Council Bluffs 6
Hong Kong 6
Mexico City 4
Seoul 4
Viterbo 4
Amsterdam 3
Bari 3
Da Nang 3
Frankfurt am Main 3
Memphis 3
Pavia 3
Albanella 2
Belo Horizonte 2
Biên Hòa 2
Cairo 2
Caserta 2
City of London 2
Hangzhou 2
Helsinki 2
Limburg an der Lahn 2
Manuel J. Cobo 2
Orem 2
Rio Paranaíba 2
Rome 2
San Cesareo 2
San Luis 2
São Paulo 2
Vienna 2
Vũng Tàu 2
Alexandria 1
An Giang Province 1
Ankara 1
Anápolis 1
Baghdad 1
Bengaluru 1
Bucaramanga 1
Cabo Frio 1
Cachoeira do Sul 1
Campos do Jordão 1
Cao Lanh 1
Cape Town 1
Chon Buri 1
Cuiabá 1
Detroit 1
Dublin 1
Giugliano in Campania 1
Guardea 1
Guayaquil 1
Hamilton 1
Harbin 1
Hải Dương 1
Ipoh 1
Jinan 1
Johannesburg 1
Kansas City 1
Madre de Deus 1
Manaus 1
Martinópolis 1
Medellín 1
Mendoza 1
Menteng 1
Mogi das Cruzes 1
Montreal 1
Nairobi 1
Ninh Bình 1
Nottingham 1
Pekanbaru 1
Pelotas 1
Pilão Arcado 1
Ponta Grossa 1
Presidente Derqui 1
Pryluky 1
Quito 1
Quảng Ngãi 1
Riverside 1
San José 1
Senhor do Bonfim 1
Seropédica 1
São José do Rio Preto 1
São João 1
Tashkent 1
Thái Nguyên 1
Tillsonburg 1
Tokyo 1
Tân Bình 1
Uruapan 1
Varginha 1
Warsaw 1
Wonosobo 1
Totale 442
Nome #
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 119
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 112
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 105
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 99
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 94
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 85
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 85
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 78
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 25
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 25
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 16
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 2
Totale 845
Categoria #
all - tutte 1.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251 0 0 0 0 0 0 0 0 0 0 0 1
2025/2026844 20 38 47 26 71 450 48 41 35 45 17 6
Totale 845